Ginsenoside Rp1 exerts anti-inflammatory effects via activation of dendritic cells and regulatory T cells

Journal of Ginseng Research

Volumn 36, Issue 4, 2012, Pages 375-382

  Bae, Jingyu ^a   Koo, Jihye ^a   Kim, Soochan ^a   Park, Tae Yoon ^b   Kim, Mi Yeon ^a  

^a Soongsil University   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Dendritic cell; Ginsenoside Rp1; Inflammation; Panax ginseng; Regulatory T cell

Indexed keywords

EID: 84867680830     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.5142/jgr.2012.36.4.375     Document Type: Article

References (24)

1. Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol 2007;59:589-601.
2. Tode T, Kikuchi Y, Kita T, Hirata J, Imaizumi E, Nagata I. Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice. J Cancer Res Clin Oncol 1993;120:24-26.
3. Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, Im DS. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res 2004;27:429-435.
4. Oh M, Choi YH, Choi S, Chung H, Kim K, Kim SI, Kim DK, Kim ND. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol 1999;14:869-875.
5. Shin JY, Lee JM, Shin HS, Park SY, Yang JE, Cho SK, Yi TH. Anti-cancer effect of ginsenoside F2 against glioblas-toma multiforme in xenograft model in SD rats. J Ginseng Res 2012;36:86-92.
6. Park MH, Park TY, inventor. Treatment and prevention of cancer with new ginsenoside derivatives. PCT/ KR2005/001006. 2005 Jul 4.
7. Kumar A, Kumar M, Panwar M, Samarth RM, Park TY, Park MH, Kimura H. Evaluation of chemopreventive action of ginsenoside Rp1. Biofactors 2006;26:29-43.
8. Park TY, Park MH, Shin WC, Rhee MH, Seo DW, Cho JY, Kim HM. Anti-metastatic potential of ginsenoside Rp1, a novel ginsenoside derivative. Biol Pharm Bull 2008;31:1802-1805.
9. Kim BH, Lee YG, Park TY, Kim HB, Rhee MH, Cho JY. Ginsenoside Rp1, a ginsenoside derivative, blocks lipopolysaccharide-induced interleukin-1beta production via suppression of the NF-kappaB pathway. Planta Med 2009;75:321-326.
10. Shen T, Lee JH, Park MH, Lee YG, Rho HS, Kwak YS, Rhee MH, Park YC, Cho JY. Ginsenoside Rp1, a ginsenoside derivative, blocks promoter activation of iNOS and COX-2 genes by suppression of an IKKb-mediated NF-kB pathway in HEK293 cells. J Ginseng Res 2011;35:200-208.
11. Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-defi cient and transgenic mice. J Immunol 1998;161:3299-3306.
12. Bettelli E, Nicholson LB, Kuchroo VK. IL-10, a key effector regulatory cytokine in experimental autoimmune encephalomyelitis. J Autoimmun 2003;20:265-267.
13. Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007;8:457-462.
14. Feuerer M, Hill JA, Mathis D, Benoist C. Foxp3+ regulatory T cells: differentiation, specifi cation, subphenotypes. Nat Immunol 2009;10:689-695.
15. Rubtsov YP, Rasmussen JP, Chi E Y, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WR Jr et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008;28:546-558.
16. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
17. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997;9:10-16.
18. Darrasse-Jeze G, Deroubaix S, Mouquet H, Victora GD, Eisenreich T, Yao KH, Masilamani RF, Dustin ML, Rudensky A, Liu K et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med 2009;206:1853-1862.
19. + T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo. Graefes Arch Clin Exp Ophthalmol 2007;245:221-229.
20. Kim MY, Anderson G, White A, Jenkinson E, Arlt W, Martensson IL, Erlandsson L, Lane PJ. OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression. J Immunol 2005;174:6686-6691.
21. + cell differentiation. Hum Immunol 2010;71:745-750.
22. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nus-senzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005;6:1219-1227.
23. Kim S, Shim S, Choi DS, Kim JH, Kwon YB, Kwon J. Modulation of LPS-stimulated astroglial activation by ginseng total saponins. J Ginseng Res 2011;35:80-85.
24. Van der Merwe PA, Bodian DL, Daenke S, Linsley P, Davis SJ. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J Exp Med 1997;185:393-403.